Mucopolysaccharidosis Treatment Market Size

  • Report ID: 5215
  • Published Date: Sep 04, 2023
  • Report Format: PDF, PPT

Mucopolysaccharidosis Treatment Market Size

Mucopolysaccharidosis Treatment Market size is anticipated to reach USD 20 billion by the end of 2035, growing at a CAGR of 8% during the forecast period, i.e., 2023 – 2035. In the year 2022, the industry size of mucopolysaccharidosis treatment was over USD 10 billion. HSCT, also known as bone marrow transplant, involves replacing the patient's faulty bone marrow or stem cells with healthy donor cells that produce the missing enzyme. In addition to these established treatments, ongoing research and development efforts were focused on finding new therapies and improving existing ones. These efforts might include gene therapy, small molecule drugs, and other innovative approaches aimed at addressing the underlying genetic and biochemical factors contributing to MPS.

Mucopolysaccharidosis (MPS) refers to a group of rare genetic disorders known as lysosomal storage disorders. These disorders are characterized by the accumulation of glycosaminoglycans (GAGs) due to the deficiency of specific enzymes required for their breakdown within lysosomes. This leads to a range of symptoms and complications affecting various organs and systems in the body.

Mucopolysaccharidosis (MPS) Treatment Market
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:

Author Credits:  Radhika Pawar

  • Report ID: 5215
  • Published Date: Sep 04, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing demand for healthcare sector is the major factor driving the market growth.

The market size of mucopolysaccharidosis (MPS) treatment is anticipated to attain a CAGR of 8% over the forecast period, i.e., 2023 – 2035.

The major players in the market are Shire (now part of Takeda Pharmaceutical Company), Sanofi Genzyme, BioMarin Pharmaceutical, Ultragenyx Pharmaceutical, Regenxbio, Abeona Therapeutics, and others.

The hospitals segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying